摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Gd-DOTA | 83678-67-5

中文名称
——
中文别名
——
英文名称
Gd-DOTA
英文别名
Gadolinium-DOTA;gadolinium(3+);2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
Gd-DOTA化学式
CAS
83678-67-5
化学式
C16H24GdN4O8
mdl
——
分子量
557.639
InChiKey
GFSTXYOTEVLASN-UHFFFAOYSA-J
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -7.79
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    174
  • 氢给体数:
    0
  • 氢受体数:
    12

ADMET

毒理性
  • 在妊娠和哺乳期间的影响
◉ 母乳喂养期间使用总结:目前没有关于母乳喂养期间使用钆喷酸葡胺的已发表经验。一些专业组织制定的指南指出,哺乳母亲在接受含钆对比剂后,不需要中断哺乳。钆喷酸葡胺是最稳定的钆剂之一,理论上使其成为在哺乳期间使用的较安全的药物。然而,由于没有关于在母乳喂养期间使用钆喷酸葡胺的已发表经验,可能更倾向于使用其他药物,特别是在哺乳新生儿或早产儿时。 ◉ 对哺乳婴儿的影响:截至修订日期,未找到相关的已发表信息。 ◉ 对泌乳和母乳的影响:截至修订日期,未找到相关的已发表信息。
◉ Summary of Use during Lactation:There is no published experience with gadoterate during breastfeeding. Guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium. Gadoterate is one of the most stable gadolinium agents, theoretically making it one of the safer drugs to use during breastfeeding. However, because there is no published experience with gadoterate during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant. ◉ Effects in Breastfed Infants:Relevant published information was not found as of the revision date. ◉ Effects on Lactation and Breastmilk:Relevant published information was not found as of the revision date.
来源:Drugs and Lactation Database (LactMed)

反应信息

  • 作为反应物:
    描述:
    氢化铕Gd-DOTA盐酸 为溶剂, 生成 [Eu-DOTA](1-)
    参考文献:
    名称:
    Tóth, Éva; Brücher, Ernö; Lázár, István, Inorganic Chemistry, 1994, vol. 33, # 18, p. 4070 - 4076
    摘要:
    DOI:
  • 作为产物:
    描述:
    1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸gadolinium(III) trifluoromethanesulfonate三乙胺 作用下, 以 甲醇 为溶剂, 反应 48.0h, 以55%的产率得到Gd-DOTA
    参考文献:
    名称:
    High-Relaxivity Gd(III)–Hemicryptophane Complex
    摘要:
    The polytopic hemicryptophane cage HC1 combining a cyclotriveratrylene (CTV) unit and a tris(2-aminoethyl)amine (tren) moiety connected by three 2-hydroxyisophthalamide linkers was synthesized in 12 steps. The resulting highly functionalized covalent host is soluble in aqueous medium and has been used to complex Gd(III) ion. The Gd(III)@HC1 complex presents promising relaxivity properties when compared to the clinically used Dotarem MRI agent.
    DOI:
    10.1021/acs.orglett.9b00081
点击查看最新优质反应信息

文献信息

  • Lanthanide(III) Complexes of Phosphorus Acid Analogues of H <sub>4</sub> DOTA as Model Compounds for the Evaluation of the Second‐Sphere Hydration
    作者:Zuzana Kotková、Giovannia A. Pereira、Kristina Djanashvili、Jan Kotek、Jakub Rudovský、Petr Hermann、Luce Vander Elst、Robert N. Muller、Carlos F. G. C. Geraldes、Ivan Lukeš、Joop A. Peters
    DOI:10.1002/ejic.200800859
    日期:2009.1
    were observed for all other complexes. Ln III -induced 17 O NMR shift data reveal that the spatial location of the second-sphere water molecules for the two groups of complexes differs. The parameters governing the effect of the second hydration sphere on the relaxivity of the Gd III complexes of all ligands were evaluated by EPR, variable-temperature 17 O NMR spectroscopy and 1 H NMRD re-laxometry.
    五个类似 DOTA 的配体在其 Gd III 复合物的第一配位球中缺乏水分子,即次膦酸盐 H 4 DOTP H 、H 4 DOTP hm 和 H 4 DOTP Et 以及膦酸酯单酯 H 4 DOTP OEt 和 H 4 DOTP合成 OBu 的目的是探索第二水合球对 Gd III 配合物弛豫率的影响。H 4 DOTP H 、H 4 DOTP hm 和H 4 DOTP OEt 配体及其Ln III 配合物通过电位和时间分辨发光表征;Gd III 配合物在热力学上远不如 H 4 DOTA 稳定,并且在内球中没有水配位。游离配体H 4 DOTP OEt和H 4 DOTP H和H 4 DOTP OEt的Gd III复合物的晶体结构通过X射线衍射确定。配合物具有预期的八齿配位模式,具有 N 4 O 4 排列;没有水分子与 Gd III 离子结合。从 1 H 和 31 P NMR 光谱中获得了水溶液中所有五种配体的
  • Solution Structure and Relaxivity of Ln‐DOTXAZA Derivatives
    作者:Malte Holzapfel、Torben Baldau、Svenja Kerpa、Gianmarco Guadalupi、Bing Qi、Yang Liu、Wolfgang J. Parak、Wolfgang Maison
    DOI:10.1002/ejic.202200432
    日期:2022.11.17
    Gd-Based contrast agents (GBCAs) are essential reagents in clinical diagnosis via MRI. We report four members of the DOTXAZA series, which are valuable scaffolds for the assembly of new GBCAs with improved relaxivity and tailored pharmacokinetic or targeting properties by Cu-catalyzed alkyne-azide cycloaddition (CuAAC).
    Gd 基造影剂(GBCA) 是通过 MRI 进行临床诊断的重要试剂。我们报告了 DOTXAZA 系列的四个成员,它们是用于组装新 GBCA 的有价值的支架,通过 Cu 催化的炔烃-叠氮化物环加成 (CuAAC) 具有改善的弛豫性和定制的药代动力学或靶向特性。
  • Gd(III) complexes for electron–electron dipolar spectroscopy: Effects of deuteration, pH and zero field splitting
    作者:Luca Garbuio、Kaspar Zimmermann、Daniel Häussinger、Maxim Yulikov
    DOI:10.1016/j.jmr.2015.08.009
    日期:2015.10
    Spectral parameters of Gd(III) complexes are intimately linked to the performance of the Gd(III)nitroxide or Gd(III)-Gd(III) double electron-electron resonance (DEER or PELDOR) techniques, as well as to that of relaxation induced dipolar modulation enhancement (RIDME) spectroscopy with Gd(III) ions. These techniques are of interest for applications in structural biology, since they can selectively detect site-to-site distances in biomolecules or biomolecular complexes in the nanometer range. Here we report relaxation properties, echo detected EPR spectra, as well as the magnitude of the echo reduction effect in Gd(III)-nitroxide DEER for a series of Gadolinium(III) complexes with chelating agents derived from tetraazacyclododecane. We observed that solvent deuteration does not only lengthen the relaxation times of Gd(III) centers but also weakens the DEER echo reduction effect. Both of these phenomena lead to an improved signal-to-noise ratios or, alternatively, longer accessible distance range in pulse EPR measurements. The presented data enrich the knowledge on paramagnetic Gd(III) chelate complexes in frozen solutions, and can help optimize the experimental conditions for most types of the pulse measurements of the electron-electron dipolar interactions. (C) 2015 Elsevier Inc. All rights reserved.
  • High-Relaxivity Gd(III)–Hemicryptophane Complex
    作者:Estelle Godart、Augustin Long、Roselyne Rosas、Gilles Lemercier、Marion Jean、Sébastien Leclerc、Sabine Bouguet-Bonnet、Célia Godfrin、Laure-Lise Chapellet、Jean-Pierre Dutasta、Alexandre Martinez
    DOI:10.1021/acs.orglett.9b00081
    日期:2019.4.5
    The polytopic hemicryptophane cage HC1 combining a cyclotriveratrylene (CTV) unit and a tris(2-aminoethyl)amine (tren) moiety connected by three 2-hydroxyisophthalamide linkers was synthesized in 12 steps. The resulting highly functionalized covalent host is soluble in aqueous medium and has been used to complex Gd(III) ion. The Gd(III)@HC1 complex presents promising relaxivity properties when compared to the clinically used Dotarem MRI agent.
  • Tóth, Éva; Brücher, Ernö; Lázár, István, Inorganic Chemistry, 1994, vol. 33, # 18, p. 4070 - 4076
    作者:Tóth, Éva、Brücher, Ernö、Lázár, István、Tóth, Imre
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物